Overview of Dr. Prendergast
Dr. Emily Prendergast is an obstetrician/gynecologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including Intermountain Medical Center, LDS Hospital, and Abbott Northwestern Hospital. She received her medical degree from University of Arizona College of Medicine-Tucson and has been in practice 11 years. She is one of 203 doctors at Abbott Northwestern Hospital and one of 174 doctors at Intermountain Medical Center who specialize in Obstetrics & Gynecology. She has more than 10 publications and over 300 citings.
Office
910 E 26th St Ste 100
Minneapolis, MN 55404Fax+1 612-884-6363
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gynecologic Oncology, 2014 - 2017
- McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 2010 - 2014
- University of Arizona College of MedicineClass of 2010
Certifications & Licensure
- CA State Medical License 2014 - 2026
- ID State Medical License 2024 - 2026
- UT State Medical License 2022 - 2026
- MN State Medical License 2017 - 2025
- NV State Medical License 2024 - 2025
- IL State Medical License 2013 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 6 citationsAnatomic Outcomes of Robotic Assisted Supracervical Hysterectomy and Concurrent Sacrocolpopexy at a Tertiary Care Institution at Initial Adaptation of the Procedure.Emily N. Prendergast, Hayley Silver, L.L. Johnson, Melissa A. Simon, Joe Feinglass
Female Pelvic Medicine & Reconstructive Surgery. 2016-01-01 - 22 citationsThree versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort.E.N. Prendergast, M. Holzapfel, Jennifer J. Mueller, Mario M. Leitao, Camille C. Gunderson
Gynecologic Oncology. 2017-02-01 - 134 citationsA Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov...Bradley J Monk, Christine Parkinson, Myong Cheol Lim, David M O'Malley, Ana Oaknin
Journal of Clinical Oncology. 2022-12-01
Press Mentions
- More Chemo May Not Equal Better Outcomes in Ovarian CaJanuary 16th, 2017
- Hormone Replacement Therapy Improves Bone Mineral Loss After Salpingo-Oophorectomy for Ovarian CancerApril 11th, 2016
- Guidelines for Bone Scans After Oophorectomy NeededSeptember 11th, 2017
- Join now to see all
Committees
- Member, SGO-Legislation and Regulation Committee 2017 - Present
Professional Memberships
- Member
- Member
- Member
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: